(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 9.55% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.49%.
Inspire Medical Systems's revenue in 2026 is $911,981,000.On average, 21 Wall Street analysts forecast INSP's revenue for 2026 to be $28,339,992,382, with the lowest INSP revenue forecast at $26,652,938,321, and the highest INSP revenue forecast at $30,218,880,587. On average, 20 Wall Street analysts forecast INSP's revenue for 2027 to be $30,905,023,571, with the lowest INSP revenue forecast at $28,398,600,429, and the highest INSP revenue forecast at $33,506,649,052.
In 2028, INSP is forecast to generate $34,507,274,237 in revenue, with the lowest revenue forecast at $30,276,059,169 and the highest revenue forecast at $38,910,025,051.